Neuland Laboratories Limited has informed the Exchange about Schedule of meet

Neuland Laboratories Limited has submitted a communication to the NSE informing about the schedule of a board meeting. This is a standard regulatory intimation filed ahead of a board meeting, typically held to consider and approve items such as financial results, dividend, fundraising, or other material business decisions. The filing itself does not disclose the agenda, date, or specific outcomes — these are usually detailed in a separate outcome filing after the meeting concludes. Investors should watch for the follow-up announcement which will carry the actual decisions taken.